Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2022

  1. Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study

    Nutrients, Vol. 14, Núm. 1

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. COVID Isolation Eating Scale (CIES): Analysis of the impact of confinement in eating disorders and obesity—A collaborative international study

    European Eating Disorders Review

  2. Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD

    FASEB Journal, Vol. 34, Núm. 9, pp. 11816-11837

2019

  1. Cytoskeletal transgelin 2 contributes to gender-dependent adipose tissue expandability and immune function

    FASEB Journal, Vol. 33, Núm. 8, pp. 9656-9671

2014

  1. Loss of control over eating: A description of the eating disorder/obesity spectrum in women

    European Eating Disorders Review, Vol. 22, Núm. 1, pp. 25-31

2013

  1. A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction

    Diabetologia, Vol. 56, Núm. 11, pp. 2524-2537

  2. Iron and Obesity Status-Associated Insulin Resistance Influence Circulating Fibroblast-Growth Factor-23 Concentrations

    PLoS ONE, Vol. 8, Núm. 3

2012

  1. Differential insulin receptor substrate-1 (IRS1)-related modulation of neuropeptide y and proopiomelanocortin expression in nondiabetic and diabetic IRS2 -/- mice

    Endocrinology, Vol. 153, Núm. 3, pp. 1129-1140